Wells Fargo downgraded Ibotta (IBTA) to Equal Weight from Overweight with a price target of $30, down from $60. The company reported a Q2 revenue miss due to customer spending delays and a “tricky” macro environment, the analyst tells investors in a research note. The firm expects continued pressure on Ibotta’s revenue through at least year-end, with declines accelerating to the mid-teens as third party promotions remain constrained.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBTA:
- Ibotta downgraded to Underperform from Neutral at BofA
- Ibotta, Inc. Class A: Buy Rating Maintained Amidst CPID Growth Potential and Stable Revenue Outlook
- Ibotta downgraded to Market Perform from Outperform at Citizens JMP
- Ibotta Reports Mixed Q2 2025 Financial Results
- Ibotta downgraded to In Line from Outperform at Evercore ISI